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Abstract
Background: Knowledge about long-term change in health related quality of life (HQoL) among older adults after
hospitalization for treatment of depression has clinical relevance. The aim was firstly to describe the change of
HQoL one year after admission for treatment of depression, secondly to explore if improved HQoL was associated
with remission of depression at follow-up and lastly to study how HQoL in patients with remission from depression
were compared to a reference group of older persons without depression.
Method: This study had the one year follow-up information of 108 older patients (≥60 years), all hospitalized for
depression at baseline, and a reference sample of 106 community-living older adults (≥60 years) without depression.
HQoL was measured using the EuroQol Group’s EQ-5D Index and a visual analog scale (EQ-VAS). Depression and
remission were diagnosed according to ICD-10. Socio-demographic variables (age, gender, and education), depressive
symptom score (Montgomery-Aasberg Depression Rating Scale), cognitive functioning (Mini Mental State Examination
scale), instrumental activities of daily living (the Lawton and Brody’s Instrumental Activities of Daily Living Scale), and
poor general physical health (General Medical Health Rating) were included as covariates.
Results: HQoL had improved at follow-up for the total group of depressed patients, as indicated by better scores on the
EQ-5D Index and EQ-VAS. In the multivariate linear regression model, improved EQ-5D Index and EQ-VAS was significantly
better in those with remission of depression and those with better baseline physical health. In adjusted analyses, the
HQoL in patients with remission from depression at follow-up did not differ from the HQoL in a reference group without
depression.
Conclusion: Older hospital patients with depression who experienced remission one year after admission gained HQoL
and their HQoL was comparable with the HQoL in a reference group of older adults without depression when adjusting
for differences in socio-demographics and health conditions.
Background
Depression is one of the most common mental disorders
among older adults [1], and the most common mood
disorder in late life, which has led to increasing global
concern as the number of older adults rises [2, 3]. About
4 to 10 % of older adults in community settings suffer
from major depressive disorders [3, 4]. Risk factors for
depression among older adults include female gender,
physical morbidity, and an impaired level of physical and
cognitive functioning [5]. Depression has been associated
with an increased risk of mortality [5, 6], poorer outcome
of treatment of physical disorders [7, 8],and health related
quality of life in older adults [9].
Health related quality of life (HQoL) relates to the per-
ceived effects of mental and physical health on each indi-
vidual’s ability to live a fulfilling life [10, 11]; thus, it is an
important outcome measure in old age [12–14] and a
multidimensional concept [10, 15]. It exists no consensus
on the definition of HQoL or the questionnaires to use
[16]. In the present study, HQoL was understood as a
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simple index formed by an algorithm where the importance
of five health problems (mental and physical) were taken
into account and a visual analog scale where experiences of
overall health were rated [17].
Knowledge about change in HQoL after treatment of
depression among older adults is an important outcome-
measure of relevance for those with depression as well
as their family, health care planners, and health care
providers. A recent review, identified five longitudinal
studies of depressed psychogeriatric in- and outpatients
[9] with no follow up after discharge [18–21] or up to
3 months after discharge [22]. Higher severity of depres-
sive symptoms at baseline was related to poorer HQoL
at discharge [18, 20] and 3 month follow-up [22]. One
study have reported that the HQoL was significantly
better in older adults with remission compared to older
adults without remission [19]. However, this was an out-
patient study without a follow-up period after discharge.
Studies using a follow-up after discharge are needed to
better understand how remission of depression may in-
fluence change of HQoL over time.
It is known that older patients with depression may both
have poorer baseline and follow-up physical health and
HQoL than older adults without depression [21, 23]. How-
ever, as far as we know, if HQoL in patients with remission
after treatment using a long-term follow-up perspective is
comparable to those without depression when adjusting
for physical and mental health differences has yet to be
studied [9]. This is highly warranted and clinically relevant
information.
The aim of the present study was first to describe
HQoL by the EQ-5D Index and EQ-VAS in patients
with depression when first admitted to a psychogeriat-
ric unit and then 1 year after admission. Secondly, we
wanted to explore if and how improved HQoL 1 year
after admission was explained by the remission of de-
pression at follow-up, adjusting for socio-demographic
variables and baseline health conditions. Thirdly, we
aimed to compare HQoL in the group of patients with
remission from depression 1 year after admission with
a group of older community living adults without de-
pression, adjusting for differences in socio-demographic
and health conditions.
Method
This study applied data from a 1 year follow-up study to
explore the associations between changes of HQoL in hos-
pitalized psychogeriatric patients with depression and
remission at follow-up. Furthermore, HQoL data from a
cross-sectional study among older community-living adults
without depression (reference group) was compared with
HQoL data from older patients with remission from de-
pression at follow-up.
Recruitment, treatment, and follow-up of participants with
depression
Patients (aged ≥ 60 years) admitted to one of seven geriatric
psychiatry hospital units in Norway between December 1,
2009 and December 30, 2011 with an ICD-10 [24] diagno-
sis of depression or depressive disorder were evaluated for
inclusion in the study sample of depressed older adults. For
all potential participants, evaluation of inclusion and
exclusion criteria and diagnostic assessments were per-
formed by psychiatrists and psychologists experienced
in geriatric psychiatry. Previous and current episodes of
depression, together with other mental health problems
and family history of mental health problems, were also
recorded. Exclusion criteria were severe cognitive im-
pairment defined by a score ≤ 11on the Mini-Mental
State Examination-Norwegian Revised Version (MMSE-
NR) [25–27], severe aphasia, having a life-threatening med-
ical condition, or inability to complete the questionnaires.
All in-patients admitted to the psychogeriatric hospital
units received “treatment as usual” following national
guidelines for treatment of diagnosed depression. An inter-
disciplinary treatment approach, including antidepressant
medications, electro-convulsive therapy (ECT), and milieu
therapy, was applied.
Included patients were contacted and invited to a follow-
up evaluation 12 months after admission at a psychogeriat-
ric out-patient clinic or in the patient’s home by trained
project nurses, psychologists, and psychiatrists. The collec-
tion of follow-up data was completed February 24, 2014.
In all, 160 patients were included in the study sample.
Sixteen patients were excluded from the baseline due to
incomplete data, leaving 144 to participate in this study.
Three patients died before follow-up, five patients did
not consent to participate in the follow-up study, 14 did
not fulfill the evaluation of depression one year after
admission, and 14 did not answer any of the HQoL mea-
sures (EQ-5D Index or EQ-VAS). Thus, 108 participants
were included in the follow-up study.
Recruitment of the reference group
Adults aged ≥ 60 years living in a community setting were
recruited for participation in the study through advertise-
ments in the local newspaper, home nursing agencies, senior
centers, and volunteer organizations. Potential participants
were screened for depressive symptoms and cognitive im-
pairment by trained students of nursing, psychology, and
medicine. Diagnostic evaluations were done by an experi-
enced psychologist and physician in geriatric psychiatry.
History of mental health problems was recorded. Exclusion
criteria included: current depressive episode or depressive
disorder according to ICD-10 [24]; current symptoms of
other psychiatric disorders; cognitive impairment defined
by a score of <27 on the MMSE-NR; severe aphasia; a life-
threatening medical condition; inability to complete the
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study questionnaires; and inability to understand the pur-
pose of the study or to provide informed consent. In total,
215 older adults volunteered to participate in the study,
but 47 were excluded because of a MMSE-NR score below
27 points and 56 persons were excluded because of a
current ICD-10 depressive episode. Six persons who quali-
fied for study inclusion did not complete any of the required
outcome measures; thus, 106 older persons constituted the
sample without depression.
Ethics
This project was approved by the Regional Committee for
Ethics in Medical Research in South Eastern Norway. Pro-
ject nurses informed the inpatients about the research pro-
ject and invited them to participate. Students in medicine,
nursing, and psychology informed potential community-
living older adult participants about the study and invited
them to participate. Both written and oral information was
given before informed consent was signed.
Measures for patients at baseline and follow-up and the
reference group
The health-related-quality of life (HQoL) was assessed
using EuroQol Group self-report instruments; ie, including
the EuroQol Group EQ-5D descriptive system and the EQ
Visual Analog Scale (EQ-VAS). Two separate outcome vari-
ables were constructed based the EQ-5D and EQ-VAS.
TheEQ-5D questionnaire asks respondents to grade their
mobility, self-care, usual activities, pain/discomfort, and
mental health by use of one item for each condition with
three possible grades (no problems, some problems, and
major problems, ie EQ-5D-3L version of EQ-5D). This
allows 243 theoretically possible combinations or situations
[17]. A scoring algorithm based on values empirically
derived from a large scale U.K. general population sample
[17, 28] was used to transform these states into a single util-
ity value (EQ-5D Index) using the “time-trade-off tariff”.
The scores on this index range from 0 (death) to 1.0 (best
possible situation). Test-retest reliability for the dimensions
in the original version of EQ-5D were reported to range
from 0.69 to 0.94 [29]. The EQ-5D Index score was used as
the first HQoL outcome measure.
The second HQoL outcome measure was the score on
the EQ-VAS. This is a standardized 20 cm vertical visual
analog scale, with the worst imaginable state as the bottom
endpoint (=0) and the best imaginable state as the top
outcome (=100). The participants scored their current
experienced HQoL by placing a mark at the location that
best represented their state. The EQ-5D and EQ VAS were
translated, used, and found valid and reliable in Norwegian
studies [30], used in studies among adults with depression
[31–35] and in older adults with health difficulties other
than depression [30, 36, 37].
To rate the severity of depression the Montgomery-
Aasberg Depression Rating Scale (MADRS) was used. This
is a ten-item rating scale. Each item has a seven-point
rating scale from 0 to 6, giving a minimum total score of
zero and a maximum score of 60 [38]. A higher score indi-
cates more severe depression. MADRS is validated for older
adults in Norway [39], and applied in several Norwegian
studies including older adults [40–42].
The Mini-Mental-State Exam-Norwegian Revised Ver-
sion (MMSE-NR) is a 20-item interviewer-administered
assessment scale with scores ranging from0 to 30 points.
A score of 27 or more usually indicates healthy global cog-
nitive functioning [25, 27]. The MMSE-NR is a translated,
adapted, and validated version of MMSE for older adults
in Norway [26, 43].
To assess physical comorbidity The General Medical
Health Rating (GMHR), a global rating scale originally
used to evaluate medical health in patients with dementia,
was applied. One item with four response categories (Ex-
cellent-good–fair–poor) [44] comprises the rating scale.
The GMHR is highly reliable (weighted kappa = .91), trans-
lated, and used in Norwegian studies [45].
The Instrumental Activities of Daily Living (I-ADL) scale
by Lawton and Brody [46] was used to evaluate partici-
pants’ ability to perform eight instrumental activities of
daily living. In this scale, three items were scored from 1 to
3, three items were scored 1–4, and two items were scored
1–5, giving a score range from 8 to 31 points; higher scores
indicate a lower level of I-ADL function. The scale is trans-
lated and used in several Norwegian studies among older
adults [47, 48].
Socio-demographic characteristics (gender, age, and level
of education) was assessed by self-report questions that
have been used in several studies of older adults in Norway
[49, 50].
Data analysis
The statistical analysis was performed with SPSS version
22.0 (IBMSPSS, Chicago, Ill, USA) and SASv9.3. The com-
parison between those who were participating at follow-
up and those who were not was performed by χ2- and the
Mann-WhitneyU-test. According to graphical assessment
of normality, the HQoL outcomes at baseline and follow-
up for the total sample were symmetrically distributed,
and thus described as mean, standard deviation (SD), and
range and compared using a paired-sample test.
Change of HQoL (ie change in the EQ-5D Index and
EQ-VAS from baseline to follow-up) was symmetrically
distributed in patients with and without remission. Intra-
class correlation coefficient (ICC) was used to assess a de-
gree of clustering due to center-level. As no cluster effect
was shown, change in HQoL was assessed by estimating
linear regression models. Remission versus no remission
was the independent variable of primary interest. Socio-
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demographic information (gender, age, and education) and
health-related condition (physical health, MMSE-NR, I-
ADL, and MADRS) at baseline were further included as
potential confounding variables for change in HQoL.
Also, HQoL assessed by the EQ-5D Index and EQ-VAS
were symmetrically distributed in patients with remission
at follow-up and in the reference group without depres-
sion. No cluster effect on center-level was present in the
reference sample, according to ICC. Hence, linear regres-
sion models were estimated with the same confounders as
in the previous model.
Results with P-values ≤ 0.05 were regarded as statistically
significant.
Results
The baseline characteristics of the 108 depressed hospi-
talized older adults with follow-up information are pre-
sented in Table 1. There were no significant differences
between those not participating and those participating
at follow-up with respect to gender, level of education,
history of vascular disease, poor physical health, previous
history of psychiatric disease, baseline MMSE, and IADL
and MADRS scores. Those not participating were older
(mean79.1 SD 6.5 years; p < 0.01). The mean duration (SD)
from hospitalization to study inclusion was 5.2 (4.7) days,
mean duration of hospitalization was 68.2 (48.9) days, and
mean duration of follow-up from inclusion was 418.1 (48.2)
days. At follow-up, 37 (of 108, 34.2 %) patients had depres-
sion, and thus 71 had remitted from depression.
Health related quality of life (HQoL) in the patients
Characteristics of HQoL at baseline and at follow-up are
shown in Table 2. The HQoL for the total group was
improved at follow-up compared to baseline (p < 0.05).
In the multivariate linear regression models, being depressed
at follow-up was associated with poorer EQ-5D Index and
EQ-VAS than in patients with remission (Table 3). Improved
EQ-5D Index and EQ-VAS was additionally associated with
good baseline physical health. Moreover, improved EQ-VAS
was associated with a higher baseline MADRS-score. The
explained adjusted variance for EQ-5D Index and EQ-VAS
was 27.0 and 27.1 %, respectively.
Older adults with remission from depression compared to
a reference group without depression
The reference group was significantly younger, and had
better education and health (p < 0.01); see Table 4. They
had significantly less frequently presence of problems
with mobility (11/106-10.4 %) (p < 0.01), usual activities
(22/106-20.7 %) (p < 0.01) and anxiety/depression (26/
106- 24.5 %) (p < 0.05), but not less frequently presence
of problems with self-care (10/106 9.4 %) and pain/dis-
comfort (42/106- 39.7 %). The mean (SD) EQ-5D Index
and EQ-VAS was higher in the reference group: 0.88 (0.15)
and 76.65 (18.00) (p < 0.01), respectively. In adjusted linear
regression analysis controlling for socio-demographics and
health conditions the EQ-5 Index and EQ-VAS were no
longer different between the older patients with remission
from depression and the reference group of community-
living older adults without depression; see Table 5. Poorer
HQoL by EQ-5D Index and EQ-VAS was associated with
higher age, poor physical health, and higher MADRS score.
In addition, a poorer EQ-5D Index was explained by
poorer instrumental functioning. Explained adjusted
variance in EQ-5D Index and EQ-VAS was 45.1 and
46.2 %, respectively.
Discussion
To our knowledge, this is the first 1 year follow-up study
of health-related quality of life (HQoL) among hospitalized
psychogeriatric depressed patients. We found that HQoL
by EQ-5D Index and EQ-VAS was more improved in
those with remission from depression at follow-up than
those without remission, even after adjustment for socio-
demographics and baseline health conditions. The HQoL
in those with remission at follow-up was comparable with
the HQoL in a reference group of older adults when
adjusting for differences in socio-demographic and health
conditions.
The finding in the present study of a significantly im-
proved EQ-5D Index and EQ-VAS in those with remission
compared to those with depression at follow-up is analo-
gous to a previous study of psychogeriatric depressed older
out-patients [19] and of depressed adults receiving primary
care treatment [35]. However, the previous studies had ei-
ther no or a shorter follow-up.
In the present study the adjusted explained variance
for the regression models was about 27 %, similar to the
Table 1 Characteristics of depressed hospitalized patients at
baseline
Total
Number of participants 108 (100)
Socio-demographic variables
Females 77 (71.3)
Age (years) Mean (SD) 75.0 (6.6)
Education≥ 10 years N (%) 51 (47.2)
Health condition
History of cardiovascular disease N (%) 70 (64.8)
GMHR: poor health N (%) 54 (50.0)
MMSE-NR score Mean (SD) 26.3 (3.6)
I-ADL score Mean (SD) 15.2 (6.2)
History of psychiatric problems N (%) 83 (76.9)
MADRS score Mean (SD) 26.1 (8.8)
GMHR, General medical health rating scale, MMSE-NR Mini-Mental State
Examination-Norwegian revised version. I-ADL Instrumental activities of daily
living, MADRS Montgomery-Aasberg depression rating scale
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explained variance in a previous study of EQ-5D Index
in adults receiving primary health care treatment [35].
In that study, remission of depression, physical health,
depression severity, and ability to work were related to
overall EQ-5D Index at a 6 month follow-up [35]. In the
recent study of hospitalized depressed patients, as in the
previously mentioned study of depressed adults receiving
primary health care treatment, the improvement of HQoL
was not associated with socio-demographic variables such
as gender, age, and education [35].
In adjusted analyses of improved HQoL, we found that
improved EQ-VAS score was associated with worse base-
line MADRS score, while improved EQ-5D Index at
follow-up was not explained by baseline MADRS. We do
not have a firm explanation for this difference, but the two
HQoL measures are slightly different since the EQ-5D
Index uses an algorithm that includes the valuations of the
general population sample’s response to the questions
asked, while EQ-VAS does not [17]. Older adults with
more severe baseline depressive symptoms may experience
Table 2 Health-related quality of life (HRQoL) (EQ-5D presence of problems, EQ-5D Index, and EQ-VAS score) at baseline and at follow-up
stratified by group(depressed- non-depressed) and change in HQoL (EQ-5D Index, and EQ-VAS score) by group
Baseline Follow-up Change
Total Depressed Non-depressed Total Depressed Non-depressed
Number of participants 37 71
EQ-5D: Presence of problems
Mobility N (%) 56 (52.4) 57 (53.3) 26 (72.2) 30 (42.9)
Self-care N (%) 41 (38.3) 29 (27.1) 17 (47.2) 12 (17.1)
Usual activities N (%) 85 (79.5) 59 (55.1) 28 (77.8) 30 (42.8)
Pain/Discomfort N (%) 81 (75.7) 67 (62.6) 27 (75.0) 39 (55.7)
Anxiety/depression N (%) 102 (95.3) 67 (62.7) 35 (97.2) 31 (44.3)
EQ-5D-Index Mean (SD) 0.7 (0.1) 0.8 (0.1) 0.7 (0.1) 0.8 (0.1) 0.1 (0.1) −0.002 (0.1) 0.1 (0.1)
Range score 0.5 0.5 0.3 0.4 0.7 0.5 0.7
EQ-VAS Mean (SD) 42.0 (18.6) 56.9 (20.6) 43.4 (18.5) 64.3 (17.6) 16.2 (24.2) 5.7 (24.1) 21.7 (22.5)
Range mm 90 100 90 89 120.00 90.00 120.00
EQ-5D EuroQol Group 5D descriptive system (5-dimension self-report questionnaire)
EQ-5D Index Summary index score from EuroQol 5D descriptive
EQ-VAS EuroQol Group visual analog scale score
Table 3 Associations between change in theEQ-5D Index and EQ-VAS and socio-demographic and health conditions
EQ-5D Index EQ-VAS
Unadjusted Adjusted model Unadjusted Adjusted model
β (95 % CI) β 95 % CI) β 95 % CI) β (95 % CI)
Depressed at follow-up −0.118 (−0.169; −0.068)** −0.116 (−0.167; −0.064)** −17.33 (−27.04; −7.62)** −18.34 (−27.85; −8.82)**
Socio-demographic condition
Females 0.018 (−0.041; 0.077) 0.013 (−0.040; 0.066) −3.44 (−14.39; 7.50) −4.70 (−14.55; 5.15)
Age pr year 0.001 (−0.003; 0.006) 0.0004 (−0.004; 0.004) −0.71 (−1.46; 0.04) −0.67 (−1.41; 0.07)
Education≥ 10 years −0.014 (−0.068; 0.039) −0.027 (−0.077; 0.022) 1.83 (−8.07; 11.74) −2.78 (−12.08; 6.51)
Health condition
GMHR: poor health at T1 −0.076 (−0.127; −0.025)* −0.066 (−0.115; −0.017) ** −10.76 (−20.35; −1.18)* −9.34 (−18.36; −0.32)*
MMSE-NR score at T1 0.004 (−0.004; 0.011) 0.002 (−0.005; 0.010) 1.29 (−0.14; 2.72) 0.60 (−0.82; 2.02)
I-ADL score at T1 0.0004 (−0.004; 0.005) 0.002 (−0.002; 0.006) −0.34 (−1.13; 0.46) −0.15 (−0.91; 0.62)
MADRS score at T1 0.0002 (−0.003; 0.003) 0.001 (−0.001; 0.004) 0.43 (−0.11; 0.96) 0.62 (0.11; 1.14)*
Adjusted R2 (%) 27.0 27.1
EQ-5D Index Summary index score from EuroQol 5D descriptive
EQ-VAS EuroQol Group visual analog scale score
GMHR General medical health rating scale
MMSE-NR Mini-mental state examination-norwegian revised version
I-ADL Instrumental activities of daily living
MADRS Montgomery-Aasberg depression rating scale
*p-value < 0.05
**p-value < 0.01
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and report changes of EQ-VAS differently than those with
less severe baseline depressive symptoms. In line with this,
an observational study of HQoL found that older people
with depression at baseline were more likely to report im-
proved HQoL after 12 months compared to those without
baseline depression [51]. At least, it is not expected that
older adults with more severe depressive baseline symptoms
accept their health difficulties, lower their expectations, and
adjust their internal standards to level out the discrepancy
between the possible and the actual situation to a greater
degree (“response-shift”) [52] than those with less severe
depressive symptoms [9, 53].
Table 4 Characteristics of patients with remission of depression at follow-up and reference group and comparison of their
characteristics
Non-depressed Reference sample Comparison p-valuea
Number 71 (100) 106
Socio-demographic variables
Females N (%) 50 (70.4) 70 (66.0) n.s.
Age (years) Mean (SD) 75.4 (6.3) 73.0 (7.9) **
Education≥ 10 years N (%) 31 (46.3) 81 (79.4) **
Health condition
History of cardiovascular disease N (%) 48 (67.6) 25 (24.8) **
GMHR: poor health N (%) 35 (49.3) 16 (15.1) **
MMSE-NR score Mean (SD) 26.9 (3.0) 29.0 (1.1) **
I-ADL score Mean (SD) 11.3 (4.9) 9.6 (4.2) **
History of psychiatric problems N (%) 53 (74.6) 35 (33.0) **
MADRS score Mean (SD) 5.4 (4.5) 2.2 (3.9) **
aχ2-test used for comparison of categorical data and Mann–Whitney test for continuous data
GMHR General medical health rating scale
MMSE-NR Mini-mental state examination-norwegian revised version
I-ADL Instrumental activities of daily living
MADRS Montgomery-Aasberg depression rating scale
**p-value < 0.01
Table 5 The associations between the degree of QOL (EQ-5D Index and EQ-VAS) and group of older adults (patient with remission
vs reference), unadjusted and adjusted for socio-economic and health conditions
EQ-5D Index EQ-VAS
Unadjusted Adjusted Unadjusted Adjusted
95 % CI β 95 % CI β 95 % CI β 95 % CI
Patients with remission- −0.071 (−0.116; −0.026) ** 0.006 (−0.037; 0.049) −11.60 (−17.35; −5.89)** 1.68 (−3.81; 7.17)
Socio-demographic condition
Female −0.019 (−0.068;0.030) 0.028 (−0.010; 0.066) −2.21 (−8.52; 4.11) 0.72 (−4.09; 5.54)
Age in years −0.009 (−0.011;-0.006)** −0.005 (−0.008; −0.003)** −0.81 (−1.20; −0.43)** −0.41 (−0.73; −0.08)**
Education≥ 10 years 0.060 (0.012; 0.107)* −0.012 (−0.053; 0.028) 8.04 (1.94; 14.14)** −1.36 (−6.60; 3.88)
Health condition
GMHR as poor −0.191 (−0.233;-0.150)** −0.126 (−0.176; −0.076)** −26.13 (−31.31; −20.96)** −19.04 (−25.49;-12.59)**
MMSE score 0.018 (0.009;0.026)** −0.003 (−0.011; 0.005) 2.79 (1.78;3.79)** 0.53 (−0.50; 1.56)
I-ADL score −0.016 (−0.021;-0.012)** −0.005 (−0.010; −0.0002)* −1.63 (−2.23; −1.04)** 0.07 (−0.56; 0.70)
MADRS score −0.017 (−0.022;-0.011)** −0.008 (−0.013; −0.003)** −2.55 (−3.16;-1.95)** −1.38 (−2.02;-0.73)**
Adj R2 % 45.1 46.2
EQ-5D Index Summary index score from EuroQol 5D descriptive
EQ-VAS EuroQol group visual analog scale score
GMHR General medical health rating scale
MMSE-NR Mini-mental state examination-norwegian revised version
I-ADL Instrumental activities of daily living
MADRS Montgomery-Aasberg depression rating scale
*p-value < 0.05
**p-value < 0.01
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HQoL relates to the perceived effects of both mental
and physical health [10, 11], and the present study found
that those with good baseline physical health were more
likely to have improved EQ-5D Index and EQ-VAS at
follow-up compared to those with poor physical health,
independent of baseline MADRS score and remission of
depression at follow-up. Our result is in line with a longi-
tudinal study of EQ-5D Index in adults receiving primary
care treatment [35] and a two-year observational study of
community-living older adults reporting that higher phys-
ical comorbidity was associated with poorer HQoL at
follow-up both in depressed and non-depressed older
adults [23].
A simple, direct comparison of EQ-5D Index and EQ-
VAS between those with remission and a reference sample
of older adults showed that HQoL in the reference sample
was better than in the patients with remission. However,
those in the reference sample were younger and had higher
education, better cognitive and instrumental functioning,
better physical health, and lower depression symptom
scores on MADRS. Adjusting for these conditions, there
was no longer a significant differences in health related
QOL by EQ-5D Index or EQ-VAS between the two groups.
However, EQ-5DIndex may have a ceiling effect in persons
with very good health [54]. The participants in the refer-
ence group had better physical health than the patients with
remission from depression, but the reference group cannot
be characterized as very healthy. Thus, we hold it less likely
that a ceiling effect is the cause of our finding of no HQoL
difference between the reference group and the patients
with remission.
Even if the study has a number of strengths, such as
using well-known, internationally accepted diagnostic pro-
cedures for depression and having information about vari-
ables of potential importance to the outcome, like socio-
demographic and medical health variables, some limitations
need to be addressed. Firstly, the loss of patients at follow-
up (25 %) was large, and could have biased the results.
However, those who died or were not followed-up had
similar distribution of gender, level of education, history of
vascular disease, poor physical health, history of psychiatric
disease, and baseline MMSE, IADL, and MADRS scores.
Secondly, we do not have detailed information about the
treatment given (ie the antidepressant medications, ECT
and/or milieu therapy). Thirdly, the reference group was
not matched to the group of older adults with remission. In
addition to better physical and cognitive health, the refer-
ence group was younger and had better education than the
patients with remission from depression. The comparison
took these differences into account. However, there might
be rest confounding which the statistical analyses were
not able to handle. In addition, other conditions of im-
portance for HQoL than those we have studied might be
of importance; eg major life events, social support, and
social coherence [55–57]. Thus, interpretation of the re-
sults should be done with caution. Fourthly, due to the re-
cruitment process of the non-depressed participants using
advertisements in the local newspaper, home nursing of-
fices, senior centers, and various volunteer organizations,
the non-depressed group of participants should not be
regarded as representative of the general community-living
older people without depression.
Finally, the present study employed the tariffs produced
by Dolan et al. [17, 28] to calculate the EQ-5D Index. A
Swedish study of depressed adults [35] and Norwegian
studies of HQoL in older adults [30, 58] used the same
tariffs. It has been questioned if EQ-5D Index calculated
by use of valuation of health conditions in general popula-
tions is the most appropriate approach [35]. A suggested
alternative would have been to base the evaluation of indi-
viduals who actually have the health state under study
[35]. However, EQ-5D is meant to be a generic HQoL
measure and such an approach would make a comparison
between groups with different health conditions more
difficult. Conversely, the simplicity of the Index may more
poorly pick up some aspects of depression that have im-
portance for HQoL compared to a longer, generic HQoL
measure that assesses the physical, mental, and social di-
mensions of HQoL separately. However, the EuroQol
Group Questionnaire was used since it is not demanding
for older adults with restricted capacity and depression; it
is cognitively relatively simple to fill in [54]. Thus, an
additional longer HQoL measure was not used, but we
analyzed both the data from the EQ-5D Index and the
EQ-VAS, giving mainly the same results.
Conclusion
Older hospital patients with depression who experienced
remission one year after admission gained HQoL and their
HQoL was comparable with the HQoL in a reference group
of older adults without depression when adjusting for dif-
ferences in socio-demographics and health conditions.
These findings are important patient health-outcomes and
can have importance for health care planners.
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